HistoSonics CEO and President, Mike Blue

HistoSonics Appoints Mike Blue as CEO and Board Member; Completes First Close of a Series B Financing

This week, HistoSonics announced that Mike Blue joined the company as President, CEO, and board member of HistoSonics. Additionally, the company closed a Series B financing round of $8.3 million led by MVCA members Venture Investors, LLC, Wolverine Venture Fund and Grand Angels. ANN ARBOR, Mich., March 13, 2017 – HistoSonics, Inc. announced today that Mike… read more

Tumor Ablation Expert Dr. Fred Lee, Jr. Joins HistoSonics as Board Member, Senior Medical Advisor

Will Help Advance HistoSonics’ Non-Invasive Therapy Technology in Liver Tumors, Other High-Value Applications    Ann Arbor, MI – September 13, 2016 – HistoSonics, Inc. announced today that noted radiologist and tumor ablation expert Fred Lee, Jr., MD, has joined the company as Senior Medical Advisor and Board member to advance HistoSonics’ innovative tissue-destruction technology in liver… read more